Coco, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 5.194
EU - Europa 3.808
AS - Asia 3.438
SA - Sud America 616
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 98
OC - Oceania 10
AN - Antartide 1
Totale 13.338
Nazione #
US - Stati Uniti d'America 5.043
SG - Singapore 1.500
DE - Germania 1.438
CN - Cina 815
IT - Italia 610
SE - Svezia 534
BR - Brasile 489
FR - Francia 306
VN - Vietnam 277
UA - Ucraina 203
IN - India 188
GB - Regno Unito 168
IE - Irlanda 146
BD - Bangladesh 114
ID - Indonesia 96
JP - Giappone 93
FI - Finlandia 87
TR - Turchia 75
HK - Hong Kong 71
RU - Federazione Russa 67
CA - Canada 64
MX - Messico 49
PL - Polonia 46
AR - Argentina 38
AT - Austria 38
NL - Olanda 38
BE - Belgio 37
IQ - Iraq 34
ZA - Sudafrica 27
PK - Pakistan 21
CO - Colombia 20
KR - Corea 20
VE - Venezuela 19
ES - Italia 17
EC - Ecuador 16
PH - Filippine 16
SA - Arabia Saudita 13
UZ - Uzbekistan 13
CI - Costa d'Avorio 11
MY - Malesia 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 10
KE - Kenya 10
RO - Romania 10
LT - Lituania 9
CL - Cile 8
JO - Giordania 8
TN - Tunisia 8
AU - Australia 7
DZ - Algeria 7
HN - Honduras 7
JM - Giamaica 7
LV - Lettonia 7
MA - Marocco 7
UY - Uruguay 7
ET - Etiopia 6
IL - Israele 6
IR - Iran 6
CH - Svizzera 5
DK - Danimarca 5
EG - Egitto 5
KZ - Kazakistan 5
NI - Nicaragua 5
NP - Nepal 5
SN - Senegal 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
LB - Libano 4
NG - Nigeria 4
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
KG - Kirghizistan 3
MM - Myanmar 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
BW - Botswana 2
CG - Congo 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PG - Papua Nuova Guinea 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 13.152
Città #
Singapore 803
Chandler 571
Ashburn 512
San Jose 449
Los Angeles 201
New York 189
Beijing 168
Dublin 145
Jacksonville 122
Ann Arbor 121
Milan 118
San Mateo 101
Lauterbourg 98
Ho Chi Minh City 97
Hefei 87
Tokyo 86
Nanjing 84
Jakarta 80
Munich 74
Nürnberg 70
Dallas 68
Wilmington 68
Buffalo 67
Cattolica 65
Frankfurt am Main 62
Hong Kong 62
Hanoi 58
São Paulo 58
Hyderabad 57
Santa Clara 57
Rome 53
Boston 52
Houston 52
Marseille 51
Izmir 49
Chicago 46
Dearborn 42
Princeton 40
Brussels 36
Moscow 35
The Dalles 35
Woodbridge 35
Lawrence 33
Nanchang 30
Redwood City 28
Brooklyn 27
Seattle 27
Bremen 25
Orem 25
Atlanta 24
Toronto 24
Boardman 23
London 23
Nuremberg 22
St Louis 22
Stockholm 22
Council Bluffs 21
Denver 21
Helsinki 21
Kent 21
Phoenix 21
Warsaw 21
Da Nang 20
Fairfield 19
Seoul 19
Vienna 19
Norwalk 18
Shanghai 18
Zhengzhou 18
Charlotte 17
Lancaster 17
San Francisco 17
Baghdad 16
Johannesburg 16
Shenyang 16
Turku 16
Washington 16
Düsseldorf 14
Haiphong 14
Tianjin 14
Belo Horizonte 13
Brasília 13
Guangzhou 13
Hebei 13
Kunming 13
Mexico City 13
Mountain View 13
Tashkent 13
Chennai 12
Columbus 12
Detroit 12
Jiaxing 12
Rio de Janeiro 12
Abidjan 11
Curitiba 11
Lappeenranta 11
Leawood 11
Paris 11
Philadelphia 11
Changsha 10
Totale 6.349
Nome #
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 527
Combined-modality therapy in locally advanced primary rectal cancer 359
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 277
Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey 245
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer after Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome 238
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 237
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 234
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 221
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 216
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 199
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 194
Polyvinylidene Fluoride Mesh (PVDF, DynaMesh®-IPOM) in The Laparoscopic Treatment of Incisional Hernia: A Prospective Comparative Trial versus Gore® ePTFE DUALMESH® Plus. 192
Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection 186
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 185
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 183
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 182
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study 182
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 181
Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli 181
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 180
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 176
Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms 170
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 165
Advance in diagnosis and treatment of small bowel tumors: a single-center report 165
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 163
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? 158
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 153
Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience. 152
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 152
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 150
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 148
[D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium 147
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 145
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 144
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 143
Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population 140
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 140
Tumor size as a prognostic factor in patients with stage IIa colon cancer 140
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 138
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 134
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 132
Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. 132
CT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. 130
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 129
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 128
Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 127
Anastomosis configuration and technique following ileocaecal resection for Crohn’s disease: a multicentre study 124
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 123
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 121
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 120
RESTAGING LOCALLY ADVANCED RECTAL CANCER WITH MR IMAGING AFTER CHEMORADIATION THERAPY 115
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 115
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 115
Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN) 114
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 111
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. 110
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients 109
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization 109
Surgical treatment of small bowel neoplasms. 109
Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study 106
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 104
Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 104
Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study 103
Body mass index and complications following major gastrointestinal surgery: A prospective, international cohort study and meta-analysis 103
National variations in perioperative assessment and surgical management of Crohn’s disease: a multicentre study 101
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 100
Textbook Outcome in Colorectal Surgery for Cancer: An Italian Version 99
Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: Report of a case and review of the literature 99
Correction to: Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer (Annals of Surgical Oncology, (2021), 28, 5, (2801-2808), 10.1245/s10434-020-09243-6) 98
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer 98
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 96
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper 96
T1 colon cancer in the era of screening: risk factors and treatment 95
Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group 94
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer 94
Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. 94
Neutrophil to lymphocyte ratio predicts risk of nodal involvement in T1 colorectal cancer patients 94
Laparoscopic approach to recurrent incisional hernia repair: A 3-year experience 93
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial 93
Association of Delayed Surgery with Oncologic Long-term Outcomes in Patients with Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 92
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 90
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 89
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients 88
Global variation in the long-term outcomes of ypT0 rectal cancers 85
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer 85
Segmental Colonic Resection Is a Safe and Effective Treatment Option for Colon Cancer of the Splenic Flexure: A Nationwide Retrospective Study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group 85
Role and Morbidity of Protective Ileostomy after Anterior Resection for Rectal Cancer: One Centre Experience and Review of Literature 85
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer 82
Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: Prognostic factors and long term outcome 80
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis 80
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 79
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 78
Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications 78
Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy 65
Surgeons' fear of getting infected by COVID19: A global survey 63
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 59
The prognostic role of anatomo-pathological factors in colorectal cancer: an univariate analysis 48
Other tumours of the colon and rectum 35
Rectal sparing approach after preoperative radio - and/or Chemo-therapy (ReSARCh): a prospective, multicentre, observational study 33
Totale 13.338
Categoria #
all - tutte 52.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022616 0 0 12 87 29 30 8 93 21 49 155 132
2022/20231.478 216 212 93 248 79 189 75 121 165 20 33 27
2023/2024691 38 206 20 50 46 112 27 10 8 18 80 76
2024/20251.798 26 45 130 72 210 78 84 81 226 194 353 299
2025/20265.295 675 138 298 515 811 569 746 231 295 346 193 478
2026/2027859 226 439 194 0 0 0 0 0 0 0 0 0
Totale 13.338